Your browser doesn't support javascript.
loading
Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD).
Ellis, Jessica; McHugh, Neil; Pauling, John D; Bruce, Ian N; Charlton, Rachel; McGrogan, Anita; Skeoch, Sarah.
Affiliation
  • Ellis J; Department of Life Sciences, University of Bath, Bath, UK.
  • McHugh N; Rheumatology, Royal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
  • Pauling JD; Department of Life Sciences, University of Bath, Bath, UK.
  • Bruce IN; Department of Life Sciences, University of Bath, Bath, UK.
  • Charlton R; Department of Rheumatology, North Bristol NHS Trust, Westbury on Trym, UK.
  • McGrogan A; Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK.
  • Skeoch S; Department of Life Sciences, University of Bath, Bath, UK.
Lupus Sci Med ; 11(2)2024 Jul 27.
Article de En | MEDLINE | ID: mdl-39067871
ABSTRACT

OBJECTIVE:

To obtain updated estimates on the incidence and prevalence of systemic lupus erythematosus (SLE) in the UK, over the period 1990-2020, using the Clinical Practice Research Datalink (CPRD).

METHODS:

This was a retrospective cohort study using the CPRD covering the period 1990-2020. A case ascertainment algorithm was developed in line with best practice recommendations for observational research. Incidence was calculated per 100 000 person-years and point prevalence (at the mid-year point) calculated per 100 000. Results were stratified by sex.

RESULTS:

9443 SLE cases were identified. 5278 incident cases were identified (4538 women, 740 men). The overall incidence rate was 5.47 (95% CI 5.33 to 5.62) cases per 100 000 person-years. Incidence rates decreased slightly across the study period, which was more pronounced for women than men. Point prevalence increased over time, from 21.4 (95% CI 17.68 to 25.67) per 100 000 in 1990 to 107.14 (95% CI 103.26 to 111.12) per 100 000 in 2020.

CONCLUSIONS:

The observed fivefold increase in prevalence of SLE over the last 30 years, in the context of a modest decline in incidence rate, may suggest improved outcomes in SLE and has important implications for healthcare service delivery and planning in the UK.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lupus érythémateux disséminé Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Lupus Sci Med Année: 2024 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lupus érythémateux disséminé Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Lupus Sci Med Année: 2024 Type de document: Article Pays de publication: Royaume-Uni